Let’s look at the key reasons that are pushing Biodesix Inc (BDSX) to new highs

Biodesix Inc (NASDAQ: BDSX) on Friday, soared 15.44% from the previous trading day, before settling in for the closing price of $1.36. Within the past 52 weeks, BDSX’s price has moved between $1.11 and $2.21.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 24.79%. The company achieved an average annual earnings per share of 45.63%. With a float of $74.02 million, this company’s outstanding shares have now reached $145.47 million.

Considering the fact that the conglomerate employs 217 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 77.72%, operating margin of -52.71%, and the pretax margin is -66.84%.

Biodesix Inc (BDSX) Breakdown of a Key Holders of the stock

Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of Biodesix Inc is 49.12%, while institutional ownership is 40.84%. The most recent insider transaction that took place on Nov 21 ’24, was worth 122,840. In this transaction Director of this company bought 100,000 shares at a rate of $1.23, taking the stock ownership to the 31,194,935 shares. Before that another transaction happened on Nov 21 ’24, when Company’s Director bought 35,000 for $1.16, making the entire transaction worth $40,562. This insider now owns 10,411,024 shares in total.

Biodesix Inc (BDSX) Recent Fiscal highlights

Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 45.63% per share during the next fiscal year.

Biodesix Inc (NASDAQ: BDSX) Trading Performance Indicators

Biodesix Inc (BDSX) is currently performing well based on its current performance indicators. A quick ratio of 3.30 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.02.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.39, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.22 in one year’s time.

Technical Analysis of Biodesix Inc (BDSX)

Compared to the last year’s volume of 0.21 million, its volume of 0.31 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 68.43%. Additionally, its Average True Range was 0.11.

During the past 100 days, Biodesix Inc’s (BDSX) raw stochastic average was set at 49.46%, which indicates a significant decrease from 89.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 68.04% in the past 14 days, which was lower than the 68.28% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $1.4333, while its 200-day Moving Average is $1.5336. Nevertheless, the first resistance level for the watch stands at $1.6800 in the near term. At $1.7899, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.9699. If the price goes on to break the first support level at $1.3901, it is likely to go to the next support level at $1.2101. Now, if the price goes above the second support level, the third support stands at $1.1002.

Biodesix Inc (NASDAQ: BDSX) Key Stats

Market capitalization of the company is 263.64 million based on 145,467K outstanding shares. Right now, sales total 49,090 K and income totals -52,150 K. The company made 18,150 K in profit during its latest quarter, and -10,260 K in sales during its previous quarter.